Intuitive Surgical, Inc. vs Trip.com Group Ltd — how do they compare? Intuitive Surgical, Inc. trades at $419.76 (market cap $146.76B), while Trip.com Group Ltd trades at $38.75 (market cap $23.75B). The key difference: Intuitive Surgical, Inc. is far larger — about 6.2× Trip.com Group Ltd's market cap, and Trip.com Group Ltd pays a 0.42% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Trip.com Group Ltd for 79 Days on average.
| ISRG | TCOM | |
|---|---|---|
Market Cap | $146.76B | $23.75B |
Volume | 2,529,814 | 2,089,737 |
Sector | Health | Consumer Cyclical |
52-Week High | $592.85 | $78.96 |
52-Week Low | $332.02 | $37.96 |
Typical Hold Time | 84 Days | 79 Days |
Enterprise Value | $141.54B | $15.91B |
Dividend Yield | — | 0.42% |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $414.52, up 2.41% today, with strong bullish technical signals from moving averages. The company demonstrates robust fundamentals with revenue growth from $6.2B in 2022 to $10.1B in 2025 and net income margin expanding to 28.45%. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast.
ISRG maintains a dominant position in robotic surgery with expanding international growth, though valuation multiples remain elevated with a P/E of 47.64. Analyst consensus is strongly bullish with a $480.78 price target representing 16% upside potential. Key risks include competitive pressures and international market volatility, particularly in China.
Trip.com (TCOM) trades at $38.09, down 0.44% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 EPS of $1.07, beating expectations by 22%, with revenue growth of 6% year-over-year. Valuation metrics remain attractive with P/E of 7.34 and P/S of 2.6, while maintaining robust profitability with 36.9% net income margin. Recent regulatory changes have introduced competitive pressures, but international travel expansion continues to drive growth.
The stock presents a compelling value opportunity with significant upside to the $56.64 consensus price target, though regulatory headwinds and market volatility pose near-term risks. Strong cash flow generation and debt reduction support the fundamental case, while technical indicators suggest potential for near-term consolidation before upward momentum resumes.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →